Real-world assessment of renal and bone safety among patients exposed to tenofovir disoproxil fumarate-containing single tablet regimens

被引：0
|
作者：
Nkhoma, E. T. [1 ]
Rosenblatt, L. [2 ]
Myers, J. [2 ]
Villasis-Keever, A. [2 ]
Coumbis, J. [3 ]
机构：
[1] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Plainsboro, NJ USA
[3] Bristol Myers Squibb Co, Hopewell, NJ USA
来源：
ANTIVIRAL THERAPY | 2015年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P17
引用
收藏
页码：A44 / A45
页数：2
相关论文
共 50 条
  • [1] Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens
    Nkhoma, Ella T.
    Rosenblatt, Lisa
    Myers, Joel
    Villasis-Keever, Angelina
    Coumbis, John
    [J]. PLOS ONE, 2016, 11 (12):
  • [2] Renal outcomes with efavirenz plus tenofovir disoproxil fumarate/emtricitabine versus other tenofovir disoproxil fumarate-containing antiretroviral regimens among HIV-infected veterans: a national study
    LaFleur, J.
    Bress, A.
    Esker, S.
    Crook, J.
    Nyman, H.
    Bedimo, R.
    Tebas, P.
    Rosenblatt, L.
    [J]. ANTIVIRAL THERAPY, 2016, 21 : A60 - A60
  • [3] Real-world assessment of renal safety among patients with HIV infection exposed to tenofovir alafenamide
    Megarity, S.
    Rafferty, P.
    Dinsmore, W.
    Donnelly, C.
    Emerson, C.
    McCarty, E.
    Quah, S.
    [J]. HIV MEDICINE, 2017, 18 : 44 - 44
  • [4] Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B
    Jeong, Sara
    Shin, Hyun Phil
    Kim, Ha Il
    [J]. INTERVIROLOGY, 2022, 65 (02) : 94 - 103
  • [5] REAL WORLD COMPARISON OF RENAL SAFETY IN PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE VS TENOFOVIR ALAFENAMIDE FOR CHRONIC HEPATITIS B
    Zhang, Xueyun
    Hu, Qiankun
    Liu, Xiaoqin
    Huang, Yuxian
    [J]. HEPATOLOGY, 2021, 74 : 490A - 491A
  • [6] Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World Study
    Farag, Mina S.
    Fung, Scott
    Tam, Edward
    Doucette, Karen
    Wong, Alexander
    Ramji, Alnoor
    Conway, Brian
    Cooper, Curtis
    Tsoi, Keith
    Wong, Philip
    Sebastiani, Giada
    Brahmania, Mayur
    Haylock-Jacobs, Sarah
    Coffin, Carla S.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2021, 28 (06) : 942 - 950
  • [7] Real-world effectiveness and renal safety of tenofovir alafenamide fumarate among chronic hepatitis B patients in Canada
    Farag, Mina
    Fung, Scott
    Tam, Edward
    Doucette, Karen
    Wong, Alexander
    Ramji, Alnoor
    Conway, Brian
    Cooper, Curtis
    Tsoi, Keith
    Feld, Jordan
    Liem, Seng
    Coffin, Carla
    Hansen, Bettina
    Janssen, Harry
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E463 - E464
  • [8] Renal and bone effects of tenofovir-containing regimens compared in a large, real-world patient population
    Tobin, Stacey C.
    [J]. AIDS, 2017, 31 (12) : N17 - N17
  • [9] Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy
    Nishijima, Takeshi
    Kurosawa, Takuma
    Tanaka, Noriko
    Kawasaki, Yohei
    Kikuchi, Yoshimi
    Oka, Shinichi
    Gatanaga, Hiroyuki
    [J]. AIDS, 2016, 30 (10) : 1563 - 1571
  • [10] Effectiveness and safety of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet combination among HIV-infected patients in Turkey: results from a real world setting
    Mete, Bilgul
    Gunduz, Alper
    Karaosmanoglu, Hayat Kumbasar
    Gumuser, Fatma
    Bolukcu, Sibel
    Yildiz, Dilek Sevgi
    Aydin, Ozlem Altuntas
    Bilge, Bilgenur
    Dokmetas, Ilyas
    Tabak, Fehmi
    [J]. AFRICAN HEALTH SCIENCES, 2021, 21 (04) : 1593 - 1602
12345